196 related articles for article (PubMed ID: 30579787)
1. Current controversies on the role of lymphadenectomy for prostate cancer.
Chalouhy C; Gurram S; Ghavamian R
Urol Oncol; 2019 Mar; 37(3):219-226. PubMed ID: 30579787
[TBL] [Abstract][Full Text] [Related]
2. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
[TBL] [Abstract][Full Text] [Related]
3. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
4. Role of lymphadenectomy for prostate cancer: indications and controversies.
La Rochelle JC; Amling CL
Urol Clin North Am; 2011 Nov; 38(4):387-95, v. PubMed ID: 22045170
[TBL] [Abstract][Full Text] [Related]
5. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
6. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
[TBL] [Abstract][Full Text] [Related]
7. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
9. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
Peneau M; Villers A; Molinié V; Theis D; Soulié M
Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
[TBL] [Abstract][Full Text] [Related]
10. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
11. Early complications of combined pelvic lymphadenectomy and radical prostatectomy versus lymphadenectomy alone.
Livne PM; Huben RP; Wolf RM; Pontes JE
Prostate; 1986; 8(4):313-8. PubMed ID: 3714572
[TBL] [Abstract][Full Text] [Related]
12. Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy.
Taylor MA; Alemozaffar M; Master VA; Sanda MG; Filson CP
Clin Genitourin Cancer; 2019 Jun; 17(3):e494-e504. PubMed ID: 30819637
[TBL] [Abstract][Full Text] [Related]
13. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
14. Role of robot-assisted radical prostatectomy in locally advanced prostate cancer.
Saika T; Miura N; Fukumoto T; Yanagihara Y; Miyauchi Y; Kikugawa T
Int J Urol; 2018 Jan; 25(1):30-35. PubMed ID: 28901630
[TBL] [Abstract][Full Text] [Related]
15. [The role of pelvic lymphadenectomy in clinically localised prostate cancer].
Schumacher M; Burkhard FC; Studer UE
Urologe A; 2005 Jun; 44(6):645-51. PubMed ID: 15871005
[TBL] [Abstract][Full Text] [Related]
16. Extended pelvic lymph node dissection for clinically localized prostate cancer: a West Australian experience.
Picardo A; Vivian J
ANZ J Surg; 2015 Dec; 85(12):936-40. PubMed ID: 25780994
[TBL] [Abstract][Full Text] [Related]
17. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
[TBL] [Abstract][Full Text] [Related]
18. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
19. The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
Wagner M; Sokoloff M; Daneshmand S
J Urol; 2008 Feb; 179(2):408-13. PubMed ID: 18076938
[TBL] [Abstract][Full Text] [Related]
20. The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review.
Dong B; Zhan H; Luan T; Wang J
World J Surg Oncol; 2024 Feb; 22(1):68. PubMed ID: 38403658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]